An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.
How Reglan triggers Tardive Dyskinesia: pathophysiology: A Detailed Overview โ detailed background and analysis.
Reference: U.S. Food and Drug Administration (FDA)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: MedlinePlus โ Trusted Health Information
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: ClinicalTrials.gov
Authoritative source for clinical, regulatory, and public-health background reading.